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Medical Science 
HIGH DIETARY SALT AND FRUCTOSE INCREASE NFAT5 
EXPRESSION IN THE KIDNEY AND LIVER OF SPRAGUE 
DAWLEY RATS.  B. Herman1, K. Ferguson1, J. Halterman1, 2 & J. 
Fernandez2, 1Dept. of Biology and 2MA in Biomedicine Program, 
Eastern Mennonite University.  In the current diet of an average 
American, there is an increasing amount of both salt and high fructose 
corn syrup. Individuals with a higher sensitivity to salt or fructose can 
develop hypertension and metabolic syndrome. This study aimed to 
determine how the consumption of a high salt diet or a high fructose 
diet altered tissue-specific expression of the NFAT5 gene. A total of 50 
Sprague Dawley rats were put either on a control diet of 0.25% NaCl 
and 6% fructose, a 4% NaCl diet, 8% NaCl diet, or 64% fructose diet 
over the course of 8 weeks. After 8 weeks, 16 different body tissue 
samples were harvested. RNA was then purified from the samples, 
reverse transcription was used to convert the purified RNA into DNA, 
and DNA samples were then run under real-time PCR in order to 
measure expression of the NFAT5 gene. The results showed an increase 
in NFAT5 expression in the kidney medulla under a 4% NaCl diet and 
in the kidney cortex under a 64% fructose diet. The results also 
displayed an increase in NFAT5 expression in the liver under a 64% 
fructose diet and 8% NaCl diet. From this study it can be concluded 
that NFAT5 is differentially expressed in different tissues in response to 
various diets. This study was funded by The Thomas F. and Kate 
Miller Jeffress Memorial Trust, Bank of America, Trustee. 
ROLE OF THE GASTROINTESTINAL MICROBIOME IN OPIOID 
TOLERANCE.  R.A. Mischel, M. Kang, W. Dewey, & H.I. Akbarali, 
Dept. of Pharmacology & Toxicology, Virginia Commonwealth 
University, Richmond, VA 23298.  Gastrointestinal microbial dysbiosis 
is known to alter physiologic homeostasis and contribute to 
pathogenesis. Though morphine and other narcotics are the most 
widely prescribed therapy for moderate to severe pain, they have been 
noted to alter microbial composition and promote bacterial 
translocation to other tissues. Translocated microbes may then 
modulate local cell signaling and gene expression. One of the most 
immediately vulnerable compartments following bacterial 
dissemination is the intestinal wall, containing many terminal processes 
of extrinsic primary afferent neurons (EPANs) from dorsal root ganglia 
(DRG). These neurons play an integral role in analgesic tolerance, a 
major limiting factor of clinical narcotic use. Despite this, the impact of 
intestinal microbiota on the development of tolerance in these cells has 
not been well characterized. To this end, we investigated how bacterial 
depletion via broad-spectrum antibiotic treatment (ABX) impacts 
nociceptive tolerance with chronic morphine use in mice. We found 
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that ABX was effective in preventing tolerance in both the tail-
immersion and acetic acid stretch assays of behavioral nociception. 
These findings were recapitulated on a single-cell level in neurons 
isolated from DRGs; namely, ABX prevented tolerance development to 
morphine-induced reductions of excitability, as measured by increases 
of threshold potential in whole-cell current clamp recordings. These 
findings suggest that gastrointestinal flora play an important role in 
modulating the pharmacodynamic properties of morphine in mice, and 
may be a useful target of therapy in man. 
C O R R E L AT I O N O F M O L E C U L A R M A R K E R S W I T H 
QUANTIFIED FIBROSIS LEVELS OF NON-NAFLD, NAFLD, AND 
NASH LIVER SAMPLES.  S. Stoddard1,2, Z. D. Goodman3, A. 
Birerdinc2 & A. Baranova1,2, 1School of Systems Biology, College of 
Science, George Mason University Fairfax, VA, 2Center for the Study 
of Chronic Metabolic Diseases, George Mason University, Falls 
Church, VA, 3Inova Health System, Falls Church, VA.  Global 
prevalence of nonalcoholic fatty liver disease (NAFLD) is currently at 
25%, and is expected to increase as a major public health concern due 
to the current worldwide obesity epidemic. The spectrum of NAFLD 
includes nonalcoholic steatohepatitis (NASH) and steatohepatitic 
hepatocellular carcinoma (SH-HCC). Not all patients with NAFLD 
progress to NASH, and the diagnosis and grading of NAFLD/NASH is 
dependent on the “gold standard” of invasive liver biopsy. Molecular 
mechanisms behind the development and progression of this disease are 
poorly understood, and this study attempts to correlate serum 
biomarkers and adipocyte gene expression with quantified fibrotic liver 
changes in NAFLD patients. Liver biopsies from obese non-NAFLD, 
NAFLD, and NASH patients were analyzed via computerized 
morphometry to quantify levels of steatosis and fibrosis. Preliminary 
results of immunoassays on serum samples indicate a negative 
correlation of INF-γ (p<0.05), IL-4 p<0.05), and G-CSF (p<0.01) with 
percent collagen of liver biopsies.  qPCR of adipose tissue will also be 
performed for further understanding of this tissue as a driver of the 
disease process. Correlation of serum biomarker levels with amount of 
fibrosis as determined by computerized morphometry will be analyzed 
to assess potential biomarkers for use as a diagnostic and/or prognostic 
tool. 
UNDERSTANDING OMICS PROFILING EXPRESSION BY USING 
DISTANCE-BASED ANALYSIS AND NETWORK BIOLOGY.  T. 
Cui, J. R. Hamre & A. V. Baranova, School of Systems Biology, 
George Mason University, Manassas VA. 20110.  With large amount of 
Omics data being generated every day, it's important to link the omics 
profiling expression to patients who have varying degrees of disorder. 
In this study, we propose a novel approach integrating distanced-based 
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analysis and network biology to analyze transcriptomics and 
proteomics data. We used several datasets including mRNA-Seq, 
miRNA-Seq and proteomics datasets with different disease states from 
GEO, TCGA and our collaborator at NIH. Samples from each group 
were clustered close to the attractor that defines their corresponding 
space center by global distances. The invasive breast carcinoma 
mRNA-Seq dataset from TCGA showed a substantially separation 
between normal/cancer samples. Additionally, the comparison between 
colon adenocarcinoma miRNA-Seq and mRNA-Seq plot showed a 
better separation between different disease states from the former, 
which suggests the holistic miRNA landscape has superior predictive 
power and can be used as a better diagnostic and prediction tool for 
reflecting pathophysiological states of human tumors. Lastly, we 
applied our model to a HDL proteomics dataset that is from 101 
patients who have varying degrees of cardiovascular disease. We were 
able to find four key proteins that may responsible for the disease 
severity. In conclusion, using the measurement of Pearson’s holistic 
distances together with network biology analysis, we demonstrated that 
the omics profiling can be used to reflect sample’s regulatory 
landscapes of overall gene/protein expression signatures, and help us 
understand the role of diseased-associated genes/proteins in the 
complex system. 
NFAT5 IS DIFFERENTIALLY REGULATED IN THE BRAIN AND 
BLADDER OF RATS FED A 4% NACL, 8% NACL, AND 64% 
FRUCTOSE DIET.  K. M. Ferguson, J. V. B. Fernandez & J. A. 
Halterman, Dept. of Biology, Eastern Mennonite University, 
Harrisonburg VA 22802.  This research investigates the effects of a 4% 
NaCl, 8% NaCl, 64% fructose, and control diet on the expression of 
Nuclear Factor of Activated T-Cells 5 (NFAT5) in rat tissues.  In human 
health, diets low in salt lower the risk of cardiovascular disorders and 
diets low in fructose lower the risk of metabolic disorders.  However, 
“low in salt/fructose” is a relative term because studies have 
demonstrated individual differential responses to the same diets. In this 
study, the effects of salt/fructose diets on the expression of NFAT5 were 
examined in the bladder and brain of Sprague Dawley rats.  This was 
done by purifying and quantifying RNA, creating cDNA, and 
quantifying NFAT5 expression by real-time PCR.  The bladder tissue 
showed decreased expression of NFAT5 following consumption of an 
8% salt and 64% fructose diet. The brain tissue showed NFAT5 
expression is increased following consumption of a 4% salt diet. These 
results suggest that NFAT5 is differentially regulated in various tissues 
of the body in response to dietary changes. Further inquiry into the 
expression of NFAT5 in other tissues is needed in order to obtain a 
comprehensive understanding of NFAT5 regulation in the body. 
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Funding source: The Thomas F. and Kate Miller Jeffress Memorial 
Trust, Bank of America, Trustee. 
EXPLORING PHARMACOLOGICAL AND BEHAVIORAL 
MECHANISMS INVOLVED IN ALCOHOL DEPENDENCE 
DURING ADOLESCENCE.  Rabha M. Younis1,2 & Imad Damaj2, 
1Dept. of Microbiology & Genetics, 2Dept. of Pharmacology & 
Toxicology, Virginia Commonwealth University, Richmond, VA, 
23219.  Alcoholism is a serious illness that is marked by uncontrollable 
drinking and physical dependence to alcohol.  Long-term alcoholism 
has been linked to many health concerns such as cirrhosis of the liver 
and cardiovascular disease. Alcohol is one of the most commonly used 
drugs among adolescent populations. Given that adolescence is a 
unique developmental stage during which alcohol has long-term effects 
on future drug-taking behavior; it is essential to understand how early 
exposure to alcohol during adolescent may affect the abuse liability of 
the drug later in life. Our studies focus on identifying behavioral 
mechanisms involved in alcohol dependence during adolescence by 
using well-established mouse models of alcohol drinking. We 
hypothesis that exposure to alcohol during early adolescence will 
increase alcohol intake later in adulthood. We investigated the impact 
of alcohol drinking in male and female early adolescent C57BL/6J 
mice using the Drinking in the Dark (DID) model. Our results showed 
that exposure to alcohol during early adolescence enhanced ethanol 
intake later in adulthood in the DID paradigm. Our data illustrates that 
enhanced alcohol intake are affected by the duration and age of 
exposure. In addition, we conducted behavioral studies to elucidate the 
mechanisms underlining the relationship between adolescent ethanol 
exposures and enhance alcohol intake in adult mice. Our results showed 
that ethanol exposure during adolescence altered the aversive state and 
enhanced the rewarding properties of ethanol later in adulthood. 
A FORMAL EXAMINATION OF TIMING OF HEART SOUNDS 
RELATIVE TO ECG EVENTS IN COLLEGE STUDENTS.  Harold J. 
Grau & Michaela Miller, Dept. of Molecular Biol. & Chem., 
Christopher Newport Univ., Newport News, VA 23606.  During each 
cardiac cycle, the first heart sound (S1) is produced after the ventricle 
begins contracting (enters systole), the pressure from which causes the 
atrioventricular valve to slam shut.  Once the ventricle begins relaxing 
(ends systole), the semilunar valves close, creating the second heart 
sound (S2).  We recorded electrocardiograms (ECGs) and heart sounds 
from 29 female (n=17) and male (n=12) college students (all between 
the ages of 20 – 22 years of age) to see if there were any patterns to 
variations in the timing of these heart sounds relative to the beginning 
of systole (the peak R wave on the ECG) and end of systole (peak T 
wave on the ECG).  We also looked at other parameters such as heart 
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rate, height, weight, and Basal Metabolic Index (BMI) to see if any 
correlations occurred.  There were no significant differences between 
males and females (although there were differences in the distribution 
of both heart sound delays).  The timing of the heart sounds did not 
correlate with each other, nor with heart rate, but did show a significant 
(S1: P<0.01, S2: P<0.05) correlation to the BMI.  Heart rate and BMI 
did not correlate, but heart rate did correlate inversely (P<0.05) with 
the interval between S1 and S2, which was also inversely correlated 
significantly with the S1 delay (P<0.01) and with heart rate (P<0.05). 
A longer S1 delay means that the ventricle takes longer to reach the 
valve-closure pressure; a longer S2 delay indicates a longer period for 
the ventricular pressure to fall below aortic pressure.  The fact that 
these are positively correlated with BMI suggests a possible health link 
that merits further investigation. 
EFFECTS OF METHYLENE BLUE ON THE ONSET AND 
PROGRESSION OF BEHAVIORAL DEFICITS IN A TRANSGENIC 
MOUSE MODEL OF ALZHEIMER’S DISEASE.  H. J. Grau, S. E. 
Fink, Q. E. Pace, B. C. Genovese, N. Khan, E. Croushore, K. 
Whitcomb, R. A. Schendzielos, D. A. Mitrano & L. S. Webb, Dept. of 
Molecular Biol. & Chem., Christopher Newport Univ., Newport News, 
VA 23606.  Alzheimer Disease (AD) is a degenerative form of 
dementia that is associated with the accumulation of neurofibrillary 
tangles (tau protein) and amyloid=beta (AB) plaque formation. 
Methylene blue (MB) has been FDA approved for reducing protein 
aggregations in AD and other diseases.  In this study, we used a triple 
transgenic mouse model of AD (3xTg-AD) to assess any effects of MB 
on the formation of these protein tangles and deposits development 
(reported elsewhere) and on spatial learning and memory tasks 
(reported here), by comparing mice given weekly intraperitoneal 
injections of MB with those given saline injections (controls) .  We 
used the Morris Water Maze (MWM) to test for spatial learning and 
memory on mice at 3, 4.5, 6, 7.5, 9, 12, 15, and 18 months of age; mice 
were given 5 days of training (with platform), and then tested (no 
platform) on day 6.  The completed study will have 12 mice for each 
treatment at each age end-point; the data reported here include results 
from about half of that total.  While the results to date are not 
conclusive, mice at 6 and 7.5 months of age did perform better at the 
MWM training (spatial learning) than their saline counterparts.  On the 
test day, which assesses spatial memory, MB treated mice did better at 
3, 6, and 15 months of age.  Differences between the groups should 
become more evident once the data are complete. 
NEUROPATHOLOGICAL EFFECTS OF METHYLENE BLUE ON 
THE ONSET AND PROGRESSION OF ALZHEIMER’S DISEASE 
IN A TRANSGENIC MOUSE MODEL.  R. A. Schendzielos1, S. E. 
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Fink1,2, Q. E. Pace1, N. Kahn2, B. C. Genovese1, E. Croushore2, K. 
Witcomb1, D. Mitrano1,2, L. S. Webb1,2, & H. J. Grau1,2, 1Dept. of 
Molecular Biology & Chemistry and 2Program in Neuroscience, 
Christopher Newport University, Newport News VA 23606. 
Alzheimer’s disease (AD) is a neurodegenerative disease that has been 
shown to cause neurological changes in the brain, including the 
development of both amyloid-beta (Αβ) plaques and neurofibrillary 
(tau) tangles, as well as impaired cognitive functioning.  Past studies 
have shown that Methylene blue (MB), an FDA approved compound, 
can reduce the formation of protein aggregates in AD and other 
diseases.  In this study, the 3xTg-AD mouse model, which contains the 
human transgenes PS1m146V, APPSwe, and Taup301L, was used to further 
explore the effect that MB has on the development of AD, specifically 
on the accumulation of the Αβ plaques and tau tangles.  Weekly 
intraperitoneal injections of either MB (10 mg/kg) or 0.9% saline were 
given, starting at 4 weeks and continuing until either 3, 4.5, 6, 7.5, 9, 
12, or 15 months of age.  At these endpoints, the mice were 
transcardially perfused with 4% paraformaldehyde/0.1% 
glutaraldehyde, and the brains were removed and fixed for 72 hours in 
4% paraformaldehyde and then cut with a vibrating microtome at 
60µm.  The tissue samples were stained with the clone 6E10 mouse 
monoclonal antibody for Αβ plaques and with the p-tau rabbit antibody 
for the tau tangles.  Preliminary qualitative observations of the tissues 
suggest that the MB-treated mouse brains had less Αβ and tau 
accumulation; future work will incorporate quantitative analyses. 
ROLE OF VAV2 IN PODOCYTE INFLAMMASOME ACTIVATION 
A N D G L O M E R U L A R I N J U R Y D U R I N G H Y P E R -
HOMOCYSTEINEMIA.  S. M. Conley1, Z. Chen1, M. Xia1, T. W. 
Gehr2, K. M. Boini1,2 & P.L. Li1, 1Dept. of Pharmacology & 
Toxicology, 2Division of Nephrology, Internal Medicine, Virginia 
Commonwealth University, School of Medicine, Richmond, VA. 
Recently, our lab has reported that Vav2, a member of the guanine 
nucleotide exchange factor (GEF) family contributes to the activation 
of NADPH oxidase (NOX) in a membrane lipid signaling platform in 
response to elevated levels of homocysteine (Hcys). However, it 
remains unknown whether Vav2-mediated NOX activation is able to 
trigger the NLRP3 inflammasome in podocytes and thereby lead to 
podocyte dysfunction and glomerular injury associated with 
hyperhomocysteinemia (hHcys). In our experiments, murine podocytes 
were pretreated with either a Rac-1 inhibitor, NSC23766 or Vav2 
activator, uridine triphosphate (UTP) and then stimulated with Hcys for 
24 hours. Confocal microscopic analysis showed that treatment with 
UTP increased the colocalization of inflammasome proteins NLRP3 
with ASC or with caspase-1, suggesting inflammasome formation. 
However, pretreatment of podocytes with NSC23766 blocked Hcys-
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induced inflammasome formation. Similar to Hcys, Vav2 activator, 
UTP increased caspase-1 activation and consequent IL-1β production in 
podocytes. However, attenuated caspase-1 activation and lower 
IL-1βlevels were observed when podocytes were treated with 
NSC23766. Our results suggest that Vav2 is a key signaling molecule 
in mediating Hcys-induced podocyte inflammasome formation and 
activation and consequent podocyte dysfunction and glomerular injury. 
N I C O T I N E P R E V E N T S C H E M O T H E R A P Y- I N D U C E D 
PERIPHERAL NEUROPATHY IN VIVO, AND FAILS TO 
STIMULATE THE GROWTH OF LUNG CANCER CELLS OR 
INTERFERE WITH THE EFFECTIVENESS OF CHEMOTHERAPY 
IN VITRO.  S. L. Kyte1, W. Toma1, M. I. Damaj1, X. Fang2 & D.A. 
Gewirtz1, 1Dept. of Pharmacology & Toxicology and 2Dept. of 
Biochemistry & Molecular Biology, Virginia Commonwealth 
University, Richmond, VA 23298.  Chemotherapy has played a 
significant role in the treatment and survival of cancer patients. 
However, its use can lead to long-term symptoms of drug toxicity, 
including chemotherapy-induced peripheral neuropathy (CIPN), a 
result of peripheral nerve fiber dysfunction or degeneration. Paclitaxel 
(Taxol), a taxane commonly used to treat breast, lung, and ovarian 
cancers, has been found to cause CIPN in 59 to 78% of patients. There 
is currently no effective preventative or therapeutic treatment for this 
side effect. Our studies revealed that the nicotinic acetylcholine 
receptor (nAChR) agonist, nicotine, is capable of reversing and 
preventing the development of paclitaxel-induced CIPN in vivo, and 
does not interfere with the cytotoxic properties of paclitaxel in vitro. 
The use of von Frey filaments revealed that nicotine dose-dependently 
reverses and prevents paclitaxel-induced mechanical allodynia. The in 
vitro studies showed that nicotine fails to significantly stimulate growth 
of A549, H460, Lewis lung carcinoma, or human explant lung cancer 
cells. Most importantly, paclitaxel-induced H460 growth inhibition was 
not significantly attenuated by nicotine. Moreover, nicotine failed to 
alter the sub-G1 DNA content of paclitaxel-treated A549 cells. These 
findings suggest that nAChRs may be promising drug targets for the 
prevention and treatment of CIPN.  
DOWNREGULATION OF MYELIN GENE EXPRESSION IN THE 
ENTORHINAL CORTEX OF FINGOLIMOD TREATED MICE. 
Jessica L. Jurmain & Michael F. Miles, Dept. of Pharmacology & 
Toxicology, Virginia Commonwealth Univ., Richmond, Virginia, 
23298.  Studies in human and mouse models of alcoholism suggest a 
role for myelin in the development of alcohol use disorders (AUDs) 
and their associated pathologies. Myelin genes are downregulated in 
the frontal cortex of alcohol dependent patients and in mouse models of 
AUD. Studies in C57BL/6J and DBA/2J mice show correlations 
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between basal myelin gene expression and behavioral responses to 
acute ethanol exposure. Fingolimod (FTY720) is an FDA approved 
drug for the treatment of relapsing multiple sclerosis. Literature reports 
on FTY720 suggest a direct role for its receptor in demyelination and 
remyelination. The significant overlap of genes regulated in 
hippocampus of FTY720-treated immune-deficient mice with an 
ethanol responsive gene set from our laboratory included several 
myelin genes. This may suggest a common mechanism between the 
effects of FTY720 and chronic ethanol treatment on myelin gene 
expression that may be useful in elucidating a treatment for the myelin-
related pathologies associated with ethanol use. Using qRT-PCR we 
examined the effects of oral FTY720 on myelin gene expression in 
ethanol-naïve mice. There were no significant changes in myelin gene 
expression in medial prefrontal cortex, caudate putamen, or nucleus 
accumbens. Two myelin genes, Mbp and Plp, were significantly 
downregulated in the entorhinal cortex of FTY720 treated mice, and 
this downregulation was strongly correlated with the downregulation of 
NFκB and Tlr4 expression. This suggests that FTY720 may aid in 
elucidating a mechanism for demyelination associated with chronic 
ethanol use. 
MISSENSE MUTATIONS IN GONADOTROPIN-RELEASING 
HORMONE RECEPTOR GENE IN PATIENTS WITH NORMOSMIC 
IDIOPTHIC HYPOGONADOTROPIC HYPOGONADISM.  N. V. 
Zernov1, M. Y. Skoblov1,2, A. V. Baranova1,2,3,4 & K. Y. Boyarsky5, 
1Federal State Budgetary Institution Research Centre for Medical 
Genetics, Moscow, 115478, Russia, 2The Moscow Institute of Physics 
& Technology, Dolgoprudny, Moscow Region, 141700, Russia, 3Center 
for the Study of Chronic Metabolic Diseases, School of Systems 
Biology, College of Science, George Mason University, Manassas, VA, 
USA. 4Atlas Biomed Group, Moscow, 123317, Russia and 5Center of 
Human Reproduction "Genesis", Department of Obstetrics and 
Gynecology, State Pediatric Medical University, St.-Petersburg, 
194100, Russia.  Isolated hypogonadotropic hypogonadism (IHH) is a 
rare genetic disease occurring in about 1-10 cases per 100,000 births. In 
only 40% of these patients is the sense of smell is unchanged. This 
normosmic IHH (nIHH) is due to a failure of gonadotropin-releasing 
hormone (GnRH) pulsatile secretion in hypothalamus or its action in 
pituitary. In nIHH patients, mutations are identified in genes GnRH1, 
GnRHR, KISS1, KISS1R, TAC3 and TAC3R. We present our 
observations of two non-consanguineous Russian female patients 
diagnosed with nIHH. Prior to referral to fertility clinic, each patient 
underwent about 10 years of hormone replacement therapy. Treatment 
was successful in both patients who delivered phenotypically healthy 
offspring. Direct sequencing of GnRHR gene identified homozygous 
mutation c.416G>A in one patient and compound heterozygous c.
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416G>A/c.806C>T in another patient. To our knowledge, this is the 
first observation of successful pregnancy of patients lacking GnRHR 
function. 
HAS THE ERADICATION OF THE POLIO VIRUS CONTRIBUTED 
TO THE RISE IN SOLID TUMOR CASES IN RECENT YEARS?  K. 
Gwilliam1, A. Baranova1,2 & A. Birerdinc1,2, 1Center for Study of 
Chronic Metabolic Disease, College of Science, George Mason 
University, Fairfax, VA 22030 and 2Betty and Guy Beatty Center for 
Integrated Research, INOVA Health System, Falls Church, VA 22042. 
A genetically altered version of the polio virus is being used in a Phase 
I study to treat glioblastioma multiforme (GBM) at the Preston Robert 
Tisch Brain Tumor Center at Duke University by Dr. Gromeier and his 
team. The genetically engineered poliovirus, PVS-RIPO, infects cells 
that have poliovirus receptors yet is disabled from replicating in 
normal, healthy cells. This raises the question of why and how polio 
virus can target glioblastoma cells and its evolutionary origins. This 
study uses publicly available databases, including the World Health 
Organization, to assess the administration of the inactivated and oral 
polio vaccine and the correlation incidence of polio and solid tumors 
reported on a global scale. Out of 69 countries studied, from five WHO 
regions, most displayed a decline in the incidence of poliomyelitis from 
1988 onward. Many of the 69 countries also showed an increased 
number of cancer cases between 1983 to 2007. A multivariate analysis 
will be performed to determine if there is a correlation between the 
eradication of polio in the human population and the rise in solid 
tumors. Outcomes could reveal the polio virus' ability to regulate solid 
tumors as well as possible influences that vaccination may have had on 
this regulation. This information could assist in better administering the 
polio virus for the treatment of solid tumors, such as GBM, as well as 
provide valuable mechanistic and evolutionary insight into the co-
evolution of the polio virus and humans. 
EPIGENETICS IN THE ETIOLOGY OF CHRONIC DISEASES. K. 
Y. Jeong, A. Birerdinc & A. Baranova, Dept. of Biology, George Mason
University, Fairfax VA 22030 and Betty and Guy Beatty Center for
Integrated Research, Inova Health System, Falls Church VA 22042.
Several recent lines of research have shown that in addition to a
genetically predisposed profile, certain epigenetic factors play an
important role in both the development and progression of certain
chronic diseases such as NAFLD. Particularly for diseases under the
umbrella of Metabolic Syndrome, it has been demonstrated that
epigenetic as well as genetic factors play a crucial role in both the
presence and severity of these comorbidities. This article focused on
incorporating the epigenetic regulations found with the etiological
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pathways of chronic diseases. A systematic review was performed to 
assess the work done to date. The two main investigated areas inflicted 
by Metabolic Syndrome include the heart and the liver. Results found 
that the accumulation of visceral fat increases expression of lipase 
genes in the liver, leads to greater FFA mobilization and results in 
hyperlipidemia linked with Steatosis and cardiovascular diseases. 
Recruitment of cytokines released by adipocytes may be linked to 
increased DNA methylation of glucokinase gene and hypomethylation 
of hepatic cell cycle inhibitor Cdkn1a, which led to decreased and 
increased expression, respectively, and contribute to NAFLD. The 
subsequent review paper will aim to summarize and consolidate the 
relationship between the epigenetic and genetic contributions to chronic 
diseases under the umbrella of Metabolic Syndrome. 
LIPID PROFILING IN CARDIOVASCULAR RISKS.  S. 
Srivangipuram1,3, T. Cui2, J. Hamre2, B. Veytsman2, A. Birerdinc2,3 & 
A. Baranova1,2,3, 1College of Science, George Mason Univ., Fairfax VA
22030, 2School of Systems Biology, George Mason Univ., Manassas
20110, 3Center for Study of Chronic Metabolic Diseases, George
Mason Univ., Falls Church., VA., Inova Health System, Falls Church.,
VA 22042.  Different classes of High-density lipoproteins transport
cholesterol in blood and their inverse correlation with cardiovascular
disease (CVD) is well known. It is believed that HDL facilitates the
removal of excess cholesterol from peripheral tissues and delivers it to
the liver for excretion. Mass spectrometry was employed to identify
187 proteins and the amount of given protein detected in blood was
collected from 101 patients who have varying levels of cardiovascular
disease as measured by CT angiography. The HDL proteomics data was
displayed as a weighted spectrum count. The statistical software “R”
was used to perform descriptive and inferential statistics on the data. To
see if the proteins are expressed differently in diseased samples, a
preliminary analysis was conducted by comparing the median distance
of the counts to the normal space center. Since the mild severity group
was closer to the normal, these two groups were combined for distance
based analysis. There was not a gravitation of the counts towards a
specific severity. A Wilcoxon signed-rank test was used to test for
significant differences in protein expression among the different
severity groups (α=0.05). There was no significant difference in protein
expression between normal to moderate group, normal to severe, and
moderate to severe. The results suggest for further analysis by
separating the HDL binding proteins to see if they contribute to disease
severity.
FIBRONECTIN FIBRIL-ASSOCIATED GROWTH FACTORS IN 
BREAST CANCER MICROENVIRONMENTS.  Pascal Shukuru & 
Lynne Elmore, Dept. of Pathology, Virginia Commonwealth University, 
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Richmond VA  23298.  Fibronectin (FN) is expressed in many breast 
cancers (BC) and implicated in tumor progression. FN forms fibrils, 
which can bind >40 soluble growth factors, many with pro-oncogenic 
properties. Data  indicate  that  breast  adipose-derived  mesenchymal 
stem  cells  (bMSCs)  promote BC  cell  growth  and  invasion  as  well 
as  the  development  of  a FN-rich  extracellular  matrix. These 
resident  stem  cells also  express  numerous  FN  binding  growth 
factors,  including  TGF-β1, and  assembly  FN  fibrils, which bind 
latent TGF-β1 binding protein 1 (LTBP1), an activator of TGF-β1. 
These experimental data prompted us to investigate whether TGF-β1 
and/or LTBP1 co-localize with FN fibrils in clinical specimens of BC. 
Tissue microarrays were stained with Masson’s Trichrome to identify 
fibrosis. Immunohistochemistry was performed to assess protein 
expression levels and localization of TGF-β1 and LTBP-1.  Many BC 
specimens exhibited abundant FN-rich fibrotic stroma. TGF-β1 co-
localized with FN fibrils in the extracellular matrix of many BC tissues, 
while LTBP1 was expressed at variable levels in BC and stromal cells. 
These data provide a foundation for testing whether co-localization of 
FN binding growth factors (or mediator of these growth factors) and 
FN fibrils associate with severity of disease. 
ABUSE-RELATED EFFECTS OF GABAA RECEPTOR POSITIVE 
ALLOSTERIC MODULATORS IN AN ASSAY OF INTRACRANIAL 
SELF-STIMULATION IN RATS.  K.L. Schwienteck1, G. Li2, M. M. 
Poe2, J. M. Cook2, M.L. Banks1 & S.S. Negus1, 1Dept. of 
Pharmacology & Toxicology, Virginia Commonwealth University, 
Richmond, VA, 23298 and 2Dept. of Chemistry & Biochemistry, 
University of Wisconsin-Milwaukee, Milwaukee, WI, 53211. 
GABAA receptor positive allosteric modulators (GABAA PAMs) are 
used clinically but also have abuse liability.  Novel GABAA PAMs have 
been developed that vary in efficacy at, and selectively 
for, GABAA receptor subtypes that contain α1, α2 or α3 subunits. 
Intracranial self-stimulation (ICSS) is one preclinical procedure that 
has been used to evaluate abuse potential of drugs.  This study 
compared effects on ICSS produced by diazepam (high-efficacy and 
relatively non-selective), zolpidem (high-efficacy and selective 
for GABAA receptors containing an α1 subunit), and the 
compounds JY-XHe-053, XHe-II-053 and HZ-166 (intermediate-
efficacy with putative selectivity for GABAA receptors that contain α2/
α3 subunits).  Adult, male Sprague-Dawley rats (n=17) were trained in 
an ICSS procedure.  Diazepam (0.1-10 mg/kg) and zolpidem (0.032-3.2 
mg/kg) produced transient abuse-related effects at low doses.  JY-
XHe-053 (3.2-32 mg/kg) and HZ-166 (3.2-32 mg/kg) produced 
significant but weaker and less reliable effects, and XHe-II-053 (3.2-32 
mg/kg) had no effect.  These results are consistent with other evidence 
for abuse potential of diazepam and zolpidem and also suggest that 
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high efficacy and/or selectivity at α1 GABAA receptor subtypes 
contributes to abuse-related effects of GABAA PAMs. Supported by 
NIH grants R01-NS070715, R01-MH096463, and VCU School of 
Medicine.  
ANTI-INFLAMMATORY DIDOX AS A TREATMENT IN A NEW 
PROGRESSIVE MODEL OF EAE.  D. J. Adkins1, K. C. Clark2, M. 
Joslyn2, G. H. DeVries2 & J. L. Dupree2, 1Thomas Nelson Community 
College, Hampton VA, 23666 and 2Dept. of Anatomy & Neurobiology, 
Virginia Commonwealth University, 23284.  Multiple sclerosis is an 
autoimmune inflammatory disease that presents with motor, sensory 
and cognitive impairment. In this study we used a mouse model of MS, 
known as experimental autoimmune encephalomyelitis (EAE), to 
investigate the efficacy of a novel anti-inflammatory drug as a potential 
treatment for progressive MS. We induced a progressive form of EAE 
in four mice which were monitored daily as they developed the disease. 
At peak disease stage, two animals were administered the novel drug, 
known as didox, for five consecutive days. Based on previous 
observations from our lab using a chronic model of EAE, we 
hypothesized that 1) the mice at peak disease would lose specific 
axonal domains known as axon initial segments (AIS) in the brain and 
nodes of Ranvier in the spinal cord; 2) that microglia, the resident 
immune cells of the central nervous system, would make contact with 
AIS and nodes of Ranvier; and 3) that the didox treated mice would 
exhibit recovery of their AIS and nodes of Ranvier. Consistent with our 
hypothesis, we found that both AIS and nodes of Ranvier were reduced 
and microglia contacted ~20% of all AIS and all nodes of Ranvier. 
Lastly, we found a partial recovery of AIS and nodes of Ranvier in the 
didox treated mice. We conclude that in this progressive EAE model, 
didox treatment may facilitate the reclustering of proteins essential for 
AIS and node of Ranvier function.  
NETWORK ANALYSIS OF CHRONIC ETHANOL RESPONSIVE 
GENE EXPRESSION IN PREFRONTAL CORTEX REVEALS 
CONSERVED CHANGES ACROSS MOUSE AND MACAQUE. 
M.L. Smith1, J.W. Bogenpohl1, C. Helms2, M.F. Lopez3, K.A. Grant2,
H.C. Becker3 and M.F. Miles1, 1Dept. of Pharmacology & Toxicology,
Virginia Commonwealth Univ., Richmond, VA 23298, 2Dept. of
Behavioral Neuroscience, Oregon Health & Science Univ., Portland,
OR 97239, and 3Dept. of Psychiatry, Medical University of South
Carolina, Charleston, SC 29425.  Alcohol use disorder (AUD) is a
significant public health problem. Characteristic features include
craving, withdrawal, and increased consumption. Here we use two
animal models explore gene expression responses in the prefrontal
cortex (PFC). Ethanol's effect on PFC is of interest due to its role in
executive function. C57BL/6J mice were exposed to ethanol by chronic
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intermittent ethanol (CIE) with 2 bottle choice drinking. Rhesus 
macaques were exposed to ethanol using schedule induced polydipsia 
(SIP). Gene expression was measured using Affymetrix microarrays, 
and expression data was analyzed using Weighted Gene Correlated 
Network Analysis (WGCNA). With WGCNA, groups of genes 
showing significantly correlated expression in both mice and monkeys 
were identified. Gene Ontology analysis revealed that modules 
represented known biological processes including neurotransmission, 
myelination, mitochondrial respiration, and regulation of gene 
expression. These results indicate a conserved gene expression 
response to chronic ethanol exposure in mice and monkeys. These 
consensus modules, therefore, reveal biological themes in the 
conserved response to chronic ethanol exposure across species, and 
may represent therapeutic targets to modulate the behavioral features of 
AUD such as escalating ethanol consumption. 
PACLITAXEL-INDUCED NEUROPATHY AND MECHANICAL 
ALLODYNIA DO NOT CORRELATE WITH BEHAVIORAL 
DEPRESSION IN RATS.  Luke P. Legakis & S. Stevens Negus, Dept. 
of Pharmacology & Toxicology, Virginia Commonwealth University, 
Richmond, VA.  Paclitaxel is a cancer chemotherapy drug with adverse 
effects that include chemotherapy-induced peripheral neuropathy 
(CIPN), neuropathic pain, and depression of mood and behavior.  These 
adverse effects can limit the clinical use of paclitaxel and reduce patient 
well-being for decades.  Preclinical research on expression and 
treatment of paclitaxel-induced neuropathic pain has relied almost 
exclusively on hypersensitive reflex-withdrawal responses to 
mechanical or thermal stimuli as the primary measure of “pain.”  It is 
unknown if paclitaxel can also produce signs of pain-depressed 
behavior in animals. The objective of this study was to evaluate 
paclitaxel effects on rates of positively reinforced operant responding in 
rats as a measure of functional impairment and behavioral depression. 
The specific aim was to test the hypothesis that regimens of paclitaxel 
treatment sufficient to produce neuropathy and mechanical allodynia 
would also depress rates of positively reinforced operant responding in 
assays of intracranial self-stimulation (ICSS) and food-maintained 
responding. Paclitaxel decreased rates of both ICSS and food-
maintained responding in some rats, but the magnitude of depression 
was not statistically significant in analysis of group data. Moreover, in 
analysis of individual data, the magnitude of depression in rates of 
operant responding did not correlate with either IENF loss or decreases 
in mechanical sensitivity threshold. These results suggest that 
neuropathy and mechanical allodynia do not cause behavioral 
depression and may have different mechanisms than behavioral 
depression. 
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ETHANOL REGULATION OF NDRG1 AND THE EFFECTS OF 
PFC MODULATION OF NDRG1 ON DRINKING BEHAVIOR.  G. 
M. Harris, A. D. van der Vaart, S. O. Park & M. F. Miles, Dept. of
Pharmacology & Toxicology, Virginia Commonwealth University,
Richmond, VA 23298.  Multiple molecular, pathological and
neuroimaging studies show perturbation of myelin or myelin gene
expression in alcoholics. Prior microarray studies in our laboratory
found down-regulation of myelin-related genes in prefrontal cortex
(PFC) of human alcoholic post mortem tissue as well as regulation of
myelin genes by acute ethanol exposure in mouse PFC.  A measure of
acute sensitivity to ethanol that is frequently used in animal behavioral
studies is the Loss of Righting Reflex (LORR) duration. Our laboratory
has implicated N-myc down-regulated gene 1 (Ndrg1) as a potential
candidate gene that modulates ethanol-induced changes in myelin-
related gene expression and acute sensitivity to ethanol. Analysis of
PFC expression data found that Ndrg1 expression was positively
correlated with ethanol intake across the BXD panel of mice and
demonstrated that the basal levels of Ndrg1 mRNA expression in the
PFC across seven different strains of mice was inversely correlated
with LORR duration time. PFC-specific knockdown of Ndrg1 mRNA
by stereotactic injection of lentivirus expressing Ndrg1-shRNA in B6
mice, caused increased ethanol LORR duration and decreased
preference for ethanol.  While CNS Ndrg1 is thought to be expressed
mainly in oligodendrocytes, we have observed it co-localized within
neurons in the PFC. A detailed characterization of Ndrg1 regulation at
the mRNA and protein expression level following acute or chronic
ethanol in currently underway.  Viral methods are also being developed
to up-regulate Ndrg1 expression in oligodendrocytes and pyramidal
neurons within the PFC.
EFFECTS OF CHRONIC AMPHETAMINE ON BEHAVIORAL AND 
NEUROCHEMICAL EFFECTS OF COCAINE IN RATS.  Amy R. 
Johnson & S. Stevens Negus, Dept. of Pharmacology & Toxicology, 
Virginia Commonwealth Univ., Richmond, VA.  Amphetamine 
maintenance decreases cocaine use in preclinical studies and clinical 
trials. The mechanisms underlying the anti-cocaine effects of 
amphetamine are not well understood. This study evaluated abuse-
related effects of cocaine on intracranial self-stimulation (ICSS) and on 
nucleus accumbens dopamine and serotonin (NAc DA and 5HT) levels. 
We hypothesized that amphetamine maintenance would decrease both 
cocaine-induced ICSS facilitation and enhancement of NAc DA. Male 
Sprague-Dawley rats were used for all studies. For ICSS, electrodes 
were implanted in the medial forebrain bundle, and responding on a 
lever produced pulses of electrical brain stimulation in a frequency-rate 
ICSS procedure. Effects of cumulative cocaine doses (1-10 mg/kg IP) 
were determined before and after 7-day treatment with saline, 0.1 or 
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0.32 mg/kg/hr amphetamine delivered by a subcutaneous osmotic 
minipump. For microdialysis, rats were implanted with cannulae 
targeting the NAc, and dialysates were analyzed for concentrations of 
DA and 5HT before and after 10 mg/kg IP cocaine. Cocaine facilitated 
ICSS and increased NAc levels of both DA and 5HT. Amphetamine 
maintenance facilitated ICSS throughout treatment and eliminated 
cocaine-induced ICSS facilitation. Amphetamine maintenance also 
increased basal DA concentration and eliminated cocaine-stimulated 
increases in NAc DA without affecting basal 5HT concentration. These 
results suggest that amphetamine maintenance decreases abuse-related 
behavioral effects of cocaine by decreasing cocaine-induced increases 
in mesolimbic DA. Supported by R01DA026946.  
IMMUNOLOGICAL LANDSCAPE OF NSCLC: OPPORTUNITIES 
FOR INTERVENTION?  Se W. Jeong & Timothy  N.J. Bullock, Dept. 
of Pathology, University of Virginia, Charlottesville, VA 22908.  Lung 
cancer is the leading cause of annual cancer related mortality in the 
United States. More than 150,000 people in the US will die from lung 
cancer this year which will lead to roughly as many deaths as breast, 
prostate, colon, and pancreatic cancers combined. Lung cancer is also 
of global concern as tobacco use in developing countries has risen 
significantly. Stage II and III non-small cell lung cancer (NSCLC) 
patients often have a 5-year disease free survival of less than 50% even 
after surgical resection and post-operative chemotherapy and a dismal 
5% overall survival for patients with metastatic disease. Even with the 
advent of PD-1/PDL-1 checkpoint blockade immunotherapies, only 
about 20% of patients are responsive to the treatment. This limited 
scope of success may be due to our lack of understanding the immune 
landscape of NSCLCs. Therefore, we set out to characterize the 
immune composition from surgical lung resections via flow cytometry. 
We found that NSCLCs have a diverse set of checkpoint inhibitor and 
co-stimulatory molecules expressed by T cells, including PD-1, TIM-3, 
and TIGIT. Interestingly, even though PD-1 was elevated compared to a 
normal donor, the expression level was lower than either breast or 
melanoma tumor samples. In addition, regulatory T cell populations 
have a profound presence in these lung tumors. These findings suggest 
potential molecules as targets of interest for immunotherapy but also 
the importance of recognizing the diversity of immune populations that 
exist within a tumor. 
EFFECTS OF TRAUMATIC BRAIN INJURY ON OXYCODONE 
REINSTATEMENT AND PHYSICAL DEPENDENCE.  Neil B. 
Varshneya & Katherine L. Nicholson, Dept. of Pharmacology & 
Toxicology, Virginia Commonwealth University, Richmond, VA 23298. 
Epidemiological data indicate that patients who experience a traumatic 
brain injury (TBI) have an elevated risk of developing a substance use 
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disorder (SUD), however the underlying neurobiological connections 
remain unclear. We investigated the effects of TBI on the abuse-related 
effects of oxycodone in preclinical models. Our evaluation utilized a 
lateral fluid percussion injury of moderate severity in adult male 
Sprague-Dawley rats. In the first aim, we tested the hypothesis that 
moderate TBI increases the risk for relapse to an opioid use disorder as 
measured by reinstatement of lever-pressing behavior following 
extinction in an intravenous oxycodone self-administration procedure. 
In the second aim, we tested the hypothesis that moderate TBI 
increases physiological dependence to oxycodone as measured by 
decreases in food-reinforced lever-pressing behavior and increases in 
other withdrawal behaviors in both precipitated withdrawal and 
spontaneous withdrawal. In reinstatement tests, non-injured subjects 
reinstated responding under oxycodone-associated cue- and oxycodone 
prime-induced conditions, however, brain-injured subjects did not 
reinstate lever-pressing behavior under any conditions. In dependence 
tests, brain-injured subjects showed no significant differences from 
non-injured subjects in mean withdrawal scores or food-reinforced 
lever-pressing behavior. Overall, these data suggest that brain-injured 
patients with no significant pre-morbid history of opioid abuse have 
lesser risk of relapse to opioid use disorders. Supported by Department 
of Defense, W81XWH-11-1-0374. 
ETHANOL REVERSAL OF OPIOID TOLERANCE IN MICE. 
Joanna C. Jacob & William L. Dewey, Dept. of Pharmacology & 
Toxicology, Virginia Commonwealth University, Richmond, VA 23298. 
Prescription opioids are generously prescribed due to their highly 
effective antinociceptive properties, however their use is limited by a 
high abuse potential due to euphoric effects. Chronic opioid use, 
whether for clinical or recreational purposes, is often coupled with the 
use of other substances, such as ethanol. Dangerous drug interactions 
are known to occur with opioids and ethanol, yet the mechanisms are 
not understood. This led to the investigation and hypothesis that ethanol 
reverses tolerance to at least some opioid effects, such as analgesia and 
respiratory depression, ultimately leading to overdose and death. We 
found a significant and dose-dependent reversal of morphine-induced 
analgesic tolerance by ethanol, as measured by warm-water tail 
withdrawal in Swiss Webster mice. Similar studies were carried out for 
oxycodone and hydrocodone, where analgesic tolerance was developed 
via chronic s.c. injections of an ED80 dose, and then altered by a single 
i.p. injection of 1g/kg ethanol. The ED50 for oxycodone was
significantly shifted from 0.9 mg/kg (0.72 – 1.12) to 1.70 mg/kg (1.42
– 2.03) after repeated administration and returned to 1.02 mg/kg
(0.77-1.37) after 1 g/kg ethanol administration. Similarly, the ED50 for
hydrocodone was shifted from 3.92 mg/kg (3.26 – 4.71) to 9.01 mg/kg
(6.44 – 12.62) and returned to 4.73 mg/kg (3.51 – 6.38) after 1 g/kg
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ethanol administration. Together these data support the hypothesis that 
ethanol reverses analgesic tolerance to opioid drugs in addition to 
morphine, and could be working through the same mechanisms.  
PROLIFERATIVE RECOVERY AND REVERSIBILITY OF 
THERAPY-INDUCED SENESCENCE IN NON-SMALL CELL 
LUNG CANCER.  Tareq Saleh & David A. Gewirtz, Virginia 
Commonwealth Univ., Dept. of Pharmacology & Toxicology, 
Richmond, VA.  Lung cancer is the leading cause of cancer-related 
death in both men and women in the United States. Most lung cancer 
cases are diagnosed in advanced, inoperable stages and are treated with 
chemoradiation; while chemoradiation is effective in suppressing tumor 
progression, recurrence following treatment is not infrequent. The 
involvement of autophagy, senescence and apoptosis in the actions of 
etoposide, one of the primary drugs utilized in the treatment of non-
small cell lung cancer (NSCLC), was studied in H460 NSCLC cells. 
Exposure to etoposide resulted in growth arrest accompanied by the 
induction of senescence, but minimal apoptosis. Growth arrest was 
transient in that proliferative recovery was evident by day 7 post 
exposure. Quantification of senescence over time based on C12FDG 
staining and flow cytometry demonstrated that the reversal of growth 
arrest coincided with a decline in the extent of senescence. To more 
precisely define the source of the recovered cells, senescent and non-
senescent but growth arrested cells were separated by flow cytometry 
based on their relative β-galactosidase expression and replated. Both 
cell populations demonstrated the ability to re-emerge from the growth-
arrested state and recover proliferative capacity. These observations 
suggest that senescence is ultimately a transient process in that at least 
a subpopulation of tumor cells can and will recover proliferative 
capacity. We propose that the reversibility of therapy-induced 
senescence (TIS) might be developed as a model for studies of tumor 
dormancy and disease recurrence. 
MOLECULAR MODELLING AND VIRTUAL SCREENING OF 
PLASMODIUM FALCIPARUM GLYCOGEN SYNTHASE KINASE 3 
(pfGSK-3) FOR ATP NON-COMPETITIVE INHIBITORS.  S. Obeng, 
S. A. Zaidi, P. D. Mosier & Y. Zhang, Dept. of Medicinal Chemistry, 
Virginia Commonwealth University, Richmond VA 23298-0540.  The 
purpose of this study was to screen for new lead compounds that are 
ATP non-competitive pfGSK-3 selective inhibitors to treat malaria. 
Since there is no crystal structure of pfGSK-3 available, a blast search 
of the PDB database was carried out. The human glycogen synthase 
kinase 3β (hGSK-3β) (PDB: 4ACC) was identified as the enzyme with 
the highest homology to pfGSK-3 with a sequence identity and 
similarity of 42.9% and 60.4% respectively. Using hGSK-3β as the 
template, 100 models of pfGSK-3 were constructed using MOD9.14. 
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The best model was selected by docking a known pfGSK-3 ATP non-
competitive inhibitor (manzamine) into a binding pocket comprising 
residues Arg 96, Arg 180, Lys 205, and Tyr 216. The best model 
obtained was used to carry out a virtual screening of the NCI and 
ZINC-sigma aldrich libraries using UNITY. The hits obtained were 
docked into the pfGSK-3 homology model using GOLD52 and the 
scoring function CHEMPLP. Three compounds with CHEMPLP scores 
of 111.07, 97.81, and 95.47 were identified as lead compounds. 
NOVEL PHOTOAFFINITY PROBES FOR α-N-TERMINAL 
WRITERS.  B. D. Mackie1, S. L. Richardson2 & R. Huang1, 1Dept. of 
Medicinal Chemistry and 2Dept. of Chemistry, Virginia Commonwealth 
University, Richmond VA 23219.  Protein α-N-terminus undergoes a 
variety of modifications including methylation, acetylation, 
myristoylation, and palmitoylation. It has been hypothesized that there 
is dynamic interplay among those modifications, such as methylation 
and acetylation. Methylation has recently demonstrated its important 
role in regulating protein-DNA interactions, mitotic division and DNA 
damage repair. Acetylation is involved in protein degradation, 
localization, and complex formation. To explore these dynamic 
modifications, we developed photoaffinity probes to profile enzymes 
that are responsible for α-N-terminal modifications. We have 
successfully synthesized a photoaffinity probe which contains three 
main components: a recognition element, a photocrosslinker, and a 
fluorescent tag. The recognition element is crucial for selectivity, the 
photocrosslinker is needed to covalently bond the probe to the target 
and the tag is necessary for fluorescence imaging. The photoaffinity 
probe’s recognition element was derived from the N-terminus of 
Retinoblastoma1 (RB1), a substrate of N-terminal methyltransferase 1 
(NTMT1). Our results suggest that our probe exhibits in a dose 
dependent, time dependent and competitive manner.  Photoaffinity 
labeling was competitively inhibited when NTMT1 was incubated with 
the probe and varying concentrations of RB1-10. The RB1 probe also 
selectively labeled NTMT1 when NTMT1 was spiked into a nuclear 
extract cell line, verifying specificity of the probe for NTMT1. Lastly, 
the probe was enzymatically methylated by NTMT1, giving further 
validation that labeling is driven by recognition. 
I M P R O V I N G T H E S I D E E F F E C T P R O F I L E O F 
ANTICOAGULANTS USING THROMBIN ALLOSTERISM.  D. K. 
Afosah1,2, S. Verespy2,3, R. Karuturi1,2, R.S. Boothelllo2 & U. R. 
Desai1,2, 1Dept. of Medicinal Chemistry and 2Institute for Structural 
Biology, Drug Discovery and Development, Virginia Commonwealth 
University, Richmond VA 23219, and 3Dept. of Chemistry, Virginia 
Commonwealth University, Richmond VA 23284.  Thrombin is a serine 
protease that occupies a central position in the coagulation cascade. Its 
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key feature is the conversion of fibrinogen to fibrin, a key component 
of blood clots. Currently, all thrombin inhibitors on the market inhibit 
the protease fully resulting in increased risk of bleeding with their use. 
We reasoned that it should be possible to develop partial inhibitors of 
thrombin that allow reasonable proteolytic activity even at saturating 
concentrations of the inhibitor. Based on our earlier work with sulfated 
benzofuran dimers, which showed 75% inhibition at saturation 
concentrations, we designed advanced analogs using computational 
virtual screening. These analogs were synthesized and their biological 
profile studied using biochemical assays. The results show that a 
distinct group of analogs display inhibition efficacies of ~50-60% at 
saturation in chromogenic substrate assay, whereas others exhibit 
efficacies of ≥80%. Similar results were observed in the fibrinogen 
assay suggesting that submaximal inhibition is maintained with 
thrombin’s in vivo substrate. The results indicate that thrombin’s high 
plasticity can be exploited to realize a clinically relevant homeostatic 
inhibitor that resolves bleeding risk. 
INTERPLAY BETWEEN ARTEMIS AND TDP1 IN SENSITIVITY 
TO RADIOMIMETIC AGENTS.  A. Kawale, K. Akopiants & L. F. 
Povirk, Dept. of Pharmacology & Toxicology, Virginia Commonwealth 
University, Richmond, VA 23298.  DNA double-strand breaks (DSBs) 
containing unligatable termini are potent cytotoxic lesions leading to 
growth arrest or cell death. Artemis, which is associated with the Non-
Homologous End Joining (NHEJ) pathway, is the major end processing 
nuclease that resolves unligatable termini, especially the 3′ blocks, by 
nucleolytic trimming. Tyrosyl-DNA Phosphodiesterase 1 (TDP1) is an 
enzyme which is biochemically competent in 3′-phosphoglycolate 
processing. The purpose of this study is to investigate if TDP1 is an 
end-processing enzyme involved in the NHEJ pathway. A cell line with 
combined deficiency in Artemis and TDP1 was generated by infecting 
Artemis-/- single mutants with a lentivirus expressing a TDP1 shRNA. 
Positive clones were screened for maximum TDP1 knockdown which 
was found to be around 14X. Clonogenic survival assays carried out on 
shTDP1 & Artemis-/- single mutants and the Artemis-/-.shTDP1 double 
mutants showed similar sensitivity to NCS and Calicheamicin. Thus, 
surprisingly, these experiments suggest that TDP1 functions are 
epistatic with Artemis in the NHEJ pathway for repair of DNA double-
strand breaks. 
HYBRID MOLECULES AS TOOLS TO STUDY CLASSICAL 5-
HT2A RECEPTOR LIGANDS.  U. H. Shah1, S. A. Gaitonde1, J. L. 
Moreno2, J. Gonzalez-Maeso2, M. Dukat1 & R. A. Glennon1, 1Dept. of 
Medicinal Chemistry, and 2Dept. of Physiology & Biophysics, Virginia 
Commonwealth University, Richmond VA 23298.  Serotonin-2A (5-
HT2A) receptor antagonists have therapeutic applications in 
Virginia Journal of Science, Vol. 67, No. 1, 2016 https://digitalcommons.odu.edu/vjs/vol67/iss1
VIRGINIA JOURNAL OF SCIENCE114
schizophrenia and belong to diverse chemical classes. Current 
pharmacophore models for 5-HT2A receptor antagonists suggest that 
these agents might have multiple binding modes. Reported 
pharmacophores include two aromatic/hydrophobic regions and a 
protonated amine. Hybrid molecules (Ket/Ris and Ris/Ket) of two 
known 5-HT2A antagonists, ketanserin (Ket) and risperidone (Ris), 
were synthesized by our laboratory to study their binding modes. 
Binding data showed that Ket/Ris (Ki = 0.96 nM) binds with 19-, 5- and 
13- fold higher affinity than Ket, Ris and Ris/Ket, respectively. The
high affinities of Ris and Ket/Ris can be attributed to an additional
bifurcated interaction as shown in homology models of 5-HT2A
receptors, which is not possible with the benzoyl ring in Ket and Ris/
Ket. We synthesized deconstructed analogs of Ris and Ket to determine
which portions contribute to 5-HT2A receptor affinity and antagonism.
4-(4-Fluorobenzoyl) piperidine and FBIP, deconstructed analogs of Ket
and Ris, respectively, were found to be 5-HT2A receptor antagonists.
Therefore, we have successfully identified a new pharmacophore for 5-
HT2A receptor antagonists that consists of one aromatic region,
hydrogen bond acceptors, and a basic protonated amine. FBIM (Ki ca
12 nM), a deconstructed analog of Ris (Ki = 5 nM), was identified as a
new high-affinity 5-HT2A receptor antagonist. Published 5-HT2A
receptor antagonist models will now need to be completely revised.
THE TALE OF THREE TESTS: PARAXODICAL MODULATION 
OF OXYCODONE-INDUCED ANTINOCICEPTION BY 
LORCASERIN.  Kumiko M. Lippold & William L. Dewey,  Dept. of 
Pharmacology & Toxicology, Virginia Commonwealth Univ., 
Richmond, VA, 23298.  Prescription opioids are important therapeutic 
agents for the treatment of pain that with chronic use, produce 
tolerance, dependence, and in many cases, addiction. There is a need to 
develop new approaches for minimizing the risk of opioid abuse and 
reducing overdose-related deaths. The underlying neurobiological 
mechanisms of these conditions suggest a modulatory role of the 
serotonergic system in the pharmacological effects of opiates. 
Lorcaserin is a selective agonist, at the serotonergic 5-HT2C receptor, 
approved by the FDA for the treatment of obesity but recently 
investigated as a potential treatment for drug abuse and dependence. 
Preclinical studies have demonstrated the efficacy of lorcaserin to 
reduce the abuse-related effects and dependence behaviors of opiates. 
We evaluated lorcaserin in the acute effects of oxycodone using tests of 
nociception and observed paradoxical modulation of the 
antinociceptive effects of oxycodone, in a divergent manner, in models 
of spinally-mediated and supraspinally-mediated thermal nociception. 
Lorcaserin potentiated the antinociception produced by oxycodone in 
the tail immersion test (a spinally-mediated reflex) and in the hot plate 
assay (a test of supraspinally-mediated pain), there was an attenuation 
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of the antinociceptive effects of oxycodone. Interestingly, lorcaserin 
also suppressed stretching activity in mice that received an 
intraperitoneal injection of acetic acid but when administered prior to 
oxycodone, no significant effects were observed. These data suggest a 
contrasting role of the 5-HT2C receptor in the effects elicited by 
oxycodone in the brain, spinal cord, and viscera. 
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